Literature DB >> 6341045

Cefaclor versus amoxicillin in the treatment of bacterial pneumonia: a comparative double-blind study.

P Leuenberger, S Vrantchev.   

Abstract

A randomized double-blind controlled trial was carried out to compare the effectiveness and side-effects of cefaclor with those of amoxicillin in the treatment of 34 patients hospitalized because of acute bacterial pulmonary infection. Cefaclor and amoxicillin were given three times daily before meals in a dosage of 500 and 750 mg respectively for seven days. The cure rate was 94% in the group of patients treated with cefaclor and 89% in the group treated with amoxicillin. According to all the parameters used to assess outcome, no significant difference was found between the two antibiotics tested. In this study, cefaclor and amoxicillin appeared to be of equal value in the treatment of bacterial pneumonia or bronchopneumonia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6341045     DOI: 10.1007/bf02019916

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  17 in total

1.  Epidemiologic characteristics of infections caused by ampicillin-resistant Hemophilus influenzae.

Authors:  J A Jacobson; J B McCormick; P Hayes; C Thornsberry; L Kirvin
Journal:  Pediatrics       Date:  1976-09       Impact factor: 7.124

2.  In vitro activity of cefaclor, a new orally administered cephalosporin antibiotic.

Authors:  J Santoro; M E Levison
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

3.  Editorial: Should ampicillin be abandoned for treatment of Haemophilus influenzae disease?

Authors:  J D Nelson
Journal:  JAMA       Date:  1974-07-15       Impact factor: 56.272

4.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

5.  Cefaclor: summary of clinical experience.

Authors:  R B Kammer; L J Short
Journal:  Infection       Date:  1979       Impact factor: 3.553

6.  Increasing incidence of ampicillin resistance in Hemophilus influenzae.

Authors:  V Syriopoulou; D Scheifele; A L Smith; P M Perry; V Howie
Journal:  J Pediatr       Date:  1978-06       Impact factor: 4.406

7.  A comparison of cefaclor and ampicillin in the treatment of respiratory infection in elderly in-patients.

Authors:  G S Lee; R Kakati; I A Mahmoud
Journal:  Curr Med Res Opin       Date:  1980       Impact factor: 2.580

8.  Comparison of in vitro antibacterial activity of three oral cephalosporins: cefaclor, cephalexin, and cephradine.

Authors:  M S Silver; G W Counts; D Zeleznik; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

9.  Cefaclor: in vitro spectrum of activity and beta-lactamase stability.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

10.  Treatment of acute bacterial bronchitis and pneumonia with cefaclor.

Authors:  W J Mogabgab; B Pollock; R B Beville; L O Gentry; J G Jemsek
Journal:  Postgrad Med J       Date:  1979       Impact factor: 2.401

View more
  2 in total

Review 1.  Treatment of respiratory tract infections with cephalosporin antibiotics.

Authors:  R Finch
Journal:  Drugs       Date:  1987       Impact factor: 9.546

2.  Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin.

Authors:  J Blaser; M N Dudley; D Gilbert; S H Zinner
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.